Meyers F J, Cardiff R D, Taylor C R, Zuniga M, Radich J
Hematol Oncol. 1984 Apr-Jun;2(2):145-50. doi: 10.1002/hon.2900020204.
The phenotype and, by inference, the cell of origin of some lymphocytic neoplasms has been defined by surface marker studies; however, the precise cellular origin of other neoplasms of the lymphoid system is still unknown. For example, with reference to hairy cell leukemia (HCL), cell marker data has been used in support of a monocytic, a T cell, or a B cell origin. If hairy cell leukemia is a B cell-derived neoplasm, the controversy may be resolved by genotyping the cells, using the rearrangement of immunoglobulin genes as a marker of the B cell nature of the process. Rearrangement of these genes is detected using the Southern blot technique and cloned probes specific for the JH segment of the immunoglobulin genes. In this study, the arrangement of the immunoglobulin genes was analysed in normal tissue, in two accepted B cell lymphomas and in nine cases of hairy cell leukemia. DNA from peripheral blood leukocytes (two patients) and from the spleen (seven patients) revealed a discrete new JH restriction fragment length in the leukocytes of hairy cell leukemia cases. The presence of rearranged restriction fragments is interpreted as evidence of the existence of clonal B cell populations. Three of six samples had rearranged kappa light chain fragments. We conclude that most cases of hairy cell leukemia have a B cell genotype. The use of genotyping has wider application in the analysis of hematological malignancies.
某些淋巴细胞肿瘤的表型以及由此推断的起源细胞已通过表面标志物研究得以明确;然而,淋巴系统其他肿瘤的确切细胞起源仍不清楚。例如,关于毛细胞白血病(HCL),细胞标志物数据曾被用于支持其起源于单核细胞、T细胞或B细胞。如果毛细胞白血病是一种源自B细胞的肿瘤,那么通过对细胞进行基因分型,以免疫球蛋白基因重排作为该过程中B细胞性质的标志物,或许可以解决这一争议。利用Southern印迹技术和针对免疫球蛋白基因JH片段的克隆探针来检测这些基因的重排。在本研究中,对正常组织、两种公认的B细胞淋巴瘤以及9例毛细胞白血病病例的免疫球蛋白基因排列进行了分析。来自外周血白细胞(2例患者)和脾脏(7例患者)的DNA显示,毛细胞白血病病例的白细胞中存在一个离散的新JH限制性片段长度。重排限制性片段的存在被解释为存在克隆性B细胞群体的证据。6个样本中有3个具有重排的κ轻链片段。我们得出结论,大多数毛细胞白血病病例具有B细胞基因型。基因分型在血液系统恶性肿瘤分析中具有更广泛的应用。